A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors

NCT05216965 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: 9MW2821

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.